- Home
- Publications
- Publication Search
- Publication Details
Title
Ganglioside Metabolism and Parkinson's Disease
Authors
Keywords
-
Journal
Frontiers in Neuroscience
Volume 12, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2018-02-05
DOI
10.3389/fnins.2018.00045
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Glucosylsphingosine Promotes α-Synuclein Pathology in Mutant GBA-Associated Parkinson's Disease
- (2017) Yumiko V. Taguchi et al. JOURNAL OF NEUROSCIENCE
- Insights from mathematical modeling for convection-enhanced intraputamenal delivery of GDNF
- (2017) Elena Belova et al. MEDICAL & BIOLOGICAL ENGINEERING & COMPUTING
- Semisynthetic and in Vitro Phosphorylation of Alpha-Synuclein at Y39 Promotes Functional Partly Helical Membrane-Bound States Resembling Those Induced by PD Mutations
- (2016) Igor Dikiy et al. ACS Chemical Biology
- Protein degradation in a LAMP-2-deficient B-lymphoblastoid cell line from a patient with Danon disease
- (2016) Raul Sánchez-Lanzas et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Constipation: an emerging risk factor for Parkinson's disease?
- (2016) P. Stirpe et al. EUROPEAN JOURNAL OF NEUROLOGY
- Visual Attention and Saccadic Oculomotor Control in Parkinson's Disease
- (2015) Carsten Buhmann et al. EUROPEAN NEUROLOGY
- GDNF signaling implemented by GM1 ganglioside; failure in Parkinson's disease and GM1-deficient murine model
- (2015) Piotr Hadaczek et al. EXPERIMENTAL NEUROLOGY
- Parkinson-causing α-synuclein missense mutations shift native tetramers to monomers as a mechanism for disease initiation
- (2015) Ulf Dettmer et al. Nature Communications
- Imaging acetylcholinesterase density in peripheral organs in Parkinson's disease with 11C-donepezil PET
- (2014) Trine Gjerløff et al. BRAIN
- c-Abl phosphorylates α-synuclein and regulates its degradation: implication for α-synuclein clearance and contribution to the pathogenesis of Parkinson's disease
- (2014) Anne-Laure Mahul-Mellier et al. HUMAN MOLECULAR GENETICS
- Deciphering the Glycolipid Code of Alzheimer's and Parkinson's Amyloid Proteins Allowed the Creation of a Universal Ganglioside-Binding Peptide
- (2014) Nouara Yahi et al. PLoS One
- Mutations in B4GALNT1 (GM2 synthase) underlie a new disorder of ganglioside biosynthesis
- (2013) Gaurav V. Harlalka et al. BRAIN
- Disease duration and the integrity of the nigrostriatal system in Parkinson’s disease
- (2013) Jeffrey H. Kordower et al. BRAIN
- Regeneration of the MPTP-Lesioned Dopaminergic System after Convection-Enhanced Delivery of AAV2-GDNF
- (2013) A. P. Kells et al. JOURNAL OF NEUROSCIENCE
- GDNF Is Predominantly Expressed in the PV+ Neostriatal Interneuronal Ensemble in Normal Mouse and after Injury of the Nigrostriatal Pathway
- (2012) M. Hidalgo-Figueroa et al. JOURNAL OF NEUROSCIENCE
- Deficiency of ganglioside GM1 correlates with Parkinson's disease in mice and humans
- (2012) Gusheng Wu et al. JOURNAL OF NEUROSCIENCE RESEARCH
- The fusogenic tilted peptide (67–78) of α-synuclein is a cholesterol binding domain
- (2011) Jacques Fantini et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES
- Gaucher Disease Glucocerebrosidase and α-Synuclein Form a Bidirectional Pathogenic Loop in Synucleinopathies
- (2011) Joseph R. Mazzulli et al. CELL
- Molecular Basis for the Glycosphingolipid-Binding Specificity of α-Synuclein: Key Role of Tyrosine 39 in Membrane Insertion
- (2011) Jacques Fantini et al. JOURNAL OF MOLECULAR BIOLOGY
- Interventional MRI-guided Putaminal Delivery of AAV2-GDNF for a Planned Clinical Trial in Parkinson's Disease
- (2011) R Mark Richardson et al. MOLECULAR THERAPY
- Mice Lacking Major Brain Gangliosides Develop Parkinsonism
- (2011) Gusheng Wu et al. NEUROCHEMICAL RESEARCH
- Characterization of the Intracellular Localization, Processing, and Secretion of Two Glial Cell Line-Derived Neurotrophic Factor Splice Isoforms
- (2010) L. Lonka-Nevalaita et al. JOURNAL OF NEUROSCIENCE
- GM1 ganglioside in Parkinson's disease: Results of a five year open study
- (2010) Jay S. Schneider et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Gene delivery of AAV2-neurturin for Parkinson's disease: a double-blind, randomised, controlled trial
- (2010) William J Marks et al. LANCET NEUROLOGY
- Parkinson's disease tremor-related metabolic network: Characterization, progression, and treatment effects
- (2010) Hideo Mure et al. NEUROIMAGE
- Lipid Rafts As a Membrane-Organizing Principle
- (2010) D. Lingwood et al. SCIENCE
- Preferentially Increased Nitration of α-Synuclein at Tyrosine-39 in a Cellular Oxidative Model of Parkinson’s Disease
- (2009) Steven R. Danielson et al. ANALYTICAL CHEMISTRY
- Phosphotyrosine protein dynamics in cell membrane rafts of sphingosine-1-phosphate-stimulated human endothelium: Role in barrier enhancement
- (2009) Jing Zhao et al. CELLULAR SIGNALLING
- Functional Effects of AAV2-GDNF on the Dopaminergic Nigrostriatal Pathway in Parkinsonian Rhesus Monkeys
- (2009) Jamie L. Eberling et al. HUMAN GENE THERAPY
- Clinically Relevant Effects of Convection-Enhanced Delivery of AAV2-GDNF on the Dopaminergic Nigrostriatal Pathway in Aged Rhesus Monkeys
- (2009) Louisa C. Johnston et al. HUMAN GENE THERAPY
- Phosphorylation, lipid raft interaction and traffic of α-synuclein in a yeast model for Parkinson
- (2008) Piotr Zabrocki et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Parkinson’s disease: genetic versus toxin-induced rodent models
- (2008) Mügen Terzioglu et al. FEBS Journal
- Oxidative and nitrative protein modifications in Parkinson's disease
- (2008) Steven R. Danielson et al. FREE RADICAL BIOLOGY AND MEDICINE
- β-Synuclein occursin vivoin lipid-associated oligomers and forms hetero-oligomers with α-synuclein
- (2008) Eitan Israeli et al. JOURNAL OF NEUROCHEMISTRY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now